Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transforaminal vs Catheter-Targeted Interlaminar ESI for Cervical Radicular Pain
NCT03382821Phase 4Completed
- Sponsor
- University of Utah
- Start
- Sep 2017
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in cervical radiculopathy comparing Transforaminal ESI with dexamethasone with Transforaminal catheter-targeted ESI with triamcinolone (2 arms). Primary endpoint: Percentage of Participants With Reduction of 50% or More of Neck and Arm Pain NRS Score at 1 month. Started Sep 2017; status: completed.
02
Drugs
dexamethasone sodium phosphatetriamcinolone acetonide
03
Conditions
cervical radiculopathy
Beyond the preview
Go deeper on NCT03382821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03382821.